Invention Grant
- Patent Title: Methods for treating antipsychotic-induced weight gain
- Patent Title (中): 治疗抗精神病药物的体重增加的方法
-
Application No.: US14297171Application Date: 2014-06-05
-
Publication No.: US09126977B2Publication Date: 2015-09-08
- Inventor: Daniel Deaver , Mark Todtenkopf
- Applicant: Alkermes Pharma Ireland Limited
- Applicant Address: IE Dublin
- Assignee: Alkermes Pharma Ireland Limited
- Current Assignee: Alkermes Pharma Ireland Limited
- Current Assignee Address: IE Dublin
- Agency: Elmore Patent Law Group, P.C.
- Agent Roy P. Issac; Carolyn S. Elmore
- Main IPC: C07D405/06
- IPC: C07D405/06 ; A61K31/439 ; A61K31/485 ; A61K31/496 ; A61K31/519 ; A61K31/5513 ; A61K31/554 ; C07D221/28
Abstract:
The present invention relates to the discovery of a novel opioid modulator effective in reducing pharmacologically induced weight gain associated with atypical antipsychotic use. The present invention provides methods of reducing antipsychotic induced weight gain, methods for suppressing food intake and reducing ghrelin levels induced by atypical antipsychotic medications in a patient.
Public/Granted literature
- US20140349999A1 METHODS FOR TREATING ANTIPSYCHOTIC-INDUCED WEIGHT GAIN Public/Granted day:2014-11-27
Information query
